Healx is an AI-powered, patient-inspired tech company, accelerating the discovery and development of treatments for rare diseases. There are 7,000 known rare diseases that affect 400 million people across the globe but only 5% of those conditions have approved treatments. Our mission is to discover and develop novel treatments for rare disease patients at scale through a combination of AI technology, drug discovery expertise and patient insight. Our innovative approach aims to identify existing drugs that may be repurposed and combined to treat rare diseases, meaning treatments can be found more quickly, efficiently and cost-effectively than traditional drug discovery methods allow. Healx was founded in 2014 in Cambridge, UK, by Dr Tim Guilliams, a Biochemical Engineer and tech entrepreneur, and Dr David Brown, co-inventor of Viagra and former Global Head of Drug Discovery at Roche. In 2019, Healx raised $56 million in Series B funding.
Click to visit Healx’s website.